Trends in surgical complexity and treatment modalities utilized in the management of ovarian cancer in an era of neoadjuvant chemotherapy
Authors:
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 154 (2) , 283-289
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Disparities in Ovarian Cancer Care Quality and Survival According to Race and Socioeconomic StatusJNCI: Journal of the National Cancer Institute, 2013
- Identification of patient groups at highest risk from traditional approach to ovarian cancer treatmentGynecologic Oncology, 2011
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian CancerNew England Journal of Medicine, 2010
- The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United StatesAnnals of Surgical Oncology, 2008
- Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancerAmerican Journal of Obstetrics and Gynecology, 2007
- Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease☆Gynecologic Oncology, 2007
- Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysisGynecologic Oncology, 2006
- The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancerGynecologic Oncology, 2006
- Determinants of Long-Term Survival After Major Surgery and the Adverse Effect of Postoperative ComplicationsAnnals of Surgery, 2005
- Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approachGynecologic Oncology, 2004